[1]常徽,陈军丽,顾业芸,等.二氢杨梅素通过抑制mTOR信号通路抑制乳腺癌细胞迁移和侵袭[J].第三军医大学学报,2018,40(18):1624-1629.
 CHANG Hui,CHEN Junli,GU Yeyun,et al.Dihydromyricetin inhibits migration and invasion of human breast cancer cells by suppressing mTOR signaling pathway[J].J Third Mil Med Univ,2018,40(18):1624-1629.
点击复制

二氢杨梅素通过抑制mTOR信号通路抑制乳腺癌细胞迁移和侵袭(/HTML )
分享到:

《第三军医大学学报》[ISSN:1000-5404/CN:51-1095/R]

卷:
40卷
期数:
2018年第18期
页码:
1624-1629
栏目:
基础医学
出版日期:
2018-09-30

文章信息/Info

Title:
Dihydromyricetin inhibits migration and invasion of human breast cancer cells by suppressing mTOR signaling pathway
作者:
常徽陈军丽顾业芸糜漫天
陆军军医大学(第三军医大学)军事预防医学系军队营养与食品卫生学教研室,重庆市营养与食品安全重点实验室,重庆市医学营养研究中心;西南大学食品科学学院;中国航天员科研训练中心营养与食品工程重点实验室
 
Author(s):
CHANG Hui CHEN Junli GU Yeyun MI Mantian

Department of Military Nutrition and Food Hygiene, Chongqing Key Laboratory of Nutrition and Food Safety, Chongqing Center of Medical Nutrition, Faculty of Military Preven tive Medicine, Army Medical University (Third Military Medical University), Chongqing, 400038; College of Food Science, Southwest University, Chongqing, 400715; Key Laboratory of Space Nutrition and Food Engineering, China Astronaut Research and Training Center, Beijing, 100094, China

关键词:
二氢杨梅素乳腺癌迁移侵袭雷帕霉素靶蛋白
Keywords:
dihydromyricetin breast cancer migration invasion mammalian target of rapamycin
文献标志码:
A
摘要:

目的     探讨二氢杨梅素(dihydromyricetin,DHM)对人乳腺癌细胞迁移和侵袭的抑制作用及其可能的分子机制。方法     以不同浓度DHM(0、10、20μmol/L和40 μmol/L)处理乳腺癌细胞MDA-MB-231,采用Transwell实验检测DHM对癌细胞迁移和侵袭能力的影响,采用蛋白印迹法检测迁移与侵袭标志蛋白(Snail、vimentin、MMP-2和MMP-9)及抑迁移蛋白E-cadherin表达的变化;同时利用乳腺癌细胞裸鼠移植瘤模型和免疫组织化学检测法,观察DHM膳食干预(100 mg/kg)对体内癌细胞迁移与侵袭相关蛋白表达的影响。结果    DHM处理乳腺癌细胞24 h,与对照组相比,细胞迁移和侵袭能力均显著降低(P<0.05),40 μmol/L处理组细胞迁移能力下降至(37.8±3.1)%,侵袭能力下降至(21.4±2.3)%;蛋白表达检测结果显示,DHM处理细胞其Snail、vimentin、MMP-2和MMP-9表达水平显著降低(P<0.01),40 μmol/L处理组蛋白表达分别下降至(31.2±2.9)%、(11.1±0.9)%、(14.4±1.2)%、(12.7±1.1)%,而E-cadherin表达水平显著升高(P<0.01),升高至(3.9±0.4)倍;体内研究结果也显示,DHM膳食干预可显著降低移植瘤组织内Snail、vimentin和MMP-9的表达,提高E-cadherin的表达(P<0.01)。进一步研究表明,DHM处理细胞24 h,与对照组相比,细胞内p-mTOR、p-4EBP1、p-S6K70 和p-eIF4B表达水平均显著降低(P<0.05),表明其mTOR信号通路被显著抑制。结论          DHM可有效抑制乳腺癌细胞的迁移和侵袭,其机制可能是通过抑制mTOR信号通路实现的。

Abstract:

Objective     To investigate the effect of dihydromyricetin (DHM) on the migration and invasion in human breast cancer cells and explore the possible molecular mechanism. Methods    Human breast cancer MDA-MB-231 cells were treated with 0, 10, 20 or 40 μmol/L DHM, and the changes in the migration and invasion of the cells were evaluated using Transwell assay. The expressionlevels of Snail, vimentin, MMP-2, MMP-9 and E-cadherin in the cells were detected by Western blotting. In nude mice bearing MDA-MB-231 cell xenograft, the effect of gastric lavage of 100 mg/kg DHM on the expression levels of these proteins in the tumor was investigated using immunohistochemistry. Results    DHM treatment for 24 h effectively inhibited the migration and invasion of breast cancer cells(P<0.05) with the dose of 40 μmol/L decreasing the migration to (37.8±3.1)% and the invasion to (21.4±2.3)%. Compared with the control cells, the DHM-treated cells exhibited significantly decreased expression of Snail, vimentin, MMP-2 and MMP-9 (P<0.01) [40 μmol/L decreasing to (31.2±2.9)%, (11.1±0.9)%,  (14.4±1.2)% and (12.7±1.1)%, repspectively ] and an increased expression of E-cadherin(the dose increasing by 3.9±0.4 times). In the tumor-bearing mice, gastric lavage of DHM significantly down-regulated the expression of Snail, vimentin and MMP-9 and increased the expression of E-cadherin in the cells xenograft (P<0.01). Treatment of MDA-MB-231 cells with DHM for 24 h also obviously reduced the phosphorylation of the downstream proteins, including mTOR, 4EBP1, S6K70 and eIF4B(P<0.05), indicating the suppression of the activation of the mammalian target of rapamycin (mTOR)  pathway. Conclusion     DHM can significantly inhibit the migration and invasion of breast cancer cells possibly by suppressing the mTOR signaling pathway.

参考文献/References:

[1]SIEGEL R L, MILLER K D, JEMAL A. Cancer statistics, 2017[J]. CA Cancer J Clin, 2017, 67(1): 7-30. DOI: 10.3322/caac.21387.
[2]水峥嵘, 唐雪元. GP73通过p53信号通路调节乳腺癌细胞MCF7的增殖和凋亡[J]. 第三军医大学学报, 2018, 40(01): 64-69. DOI: 10.16016/j.10005404. 201708074.
SHUI Z R, TANG X Y. GP73 regulates proliferation and apoptosis of breast cancer MCF7 via p53 signaling pathway[J]. J Third Mil Med Univ, 2018, 40(01): 64-69. DOI: 10.16016/j.1000 5404.201708074.
[3]黄哲宙, 陈万青, 吴春晓, 等. 北京、上海、林州和启东地区女性乳腺癌发病及死亡的时间趋势[J]. 肿瘤, 2012, 32(8): 605-608. DOI: 10.3781/j.issn.10007431.2012.08.007.
HUANG Z Z, CHEN W Q, WU C X, et al. The trends of female breast cancer incidence and mortality in Beijing, Shanghai, Linzhou and Qidong in China[J]. Tumor, 2012, 32(8): 605-608. DOI: 10.3781/j.issn.10007431. 2012.08.007.
[4]DESANTIS C E, MA J, GODING SAUER A, et al. Breast cancer statistics, 2017, racial disparity in mortality by state[J]. CA Cancer J Clin, 2017, 67(6): 439-448. DOI:10.3322/caac.21412.
[5]LU X, YAN C, HUANG Y, et al. Mouse double minute 2 (MDM2) upregulates snail expression and induces epithelialtomesenchymal transition in breast cancer cells in vitro and in vivo[J]. Oncotarget, 2016, 7(24): 37177-37191. DOI: 10. 18632/oncotarget.9287.
[6]CHOI B J, PARK S A, LEE S Y, et al. Hypoxia induces epithelialmesenchymal transition in colorectal cancer cells through ubiquitinspecific protease 47mediated stabilization of snail: a potential role of sox9[J]. Sci Rep, 2017, 7(1): 15918. DOI: 10.1038/s41598017151395.
[7]GONZLEZCHAVARRA I, FERNANDEZ E, GUTIERREZ N, et al. LOX1 activation by oxLDL triggers an epithelial mesenchymal transition and promotes tumorigenic potential in prostate cancer cells[J]. Cancer Lett, 2018, 414: 34-43. DOI: 10.1016/j.canlet.2017.10.035.
[8]YU M, XUE H, WANG Y, et al. miR345 inhibits tumor metastasis and EMT by targeting IRF1mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma[J]. Int J Oncol, 2017, 50(3): 975-983. DOI: 10.3892/ijo.2017.3852.
[9]NIU P G, ZHANG Y X, SHI D H, et al. Cardamonin inhibits metastasis of lewis lung carcinoma cells by decreasing mTOR activity[J]. PLoS ONE, 2015, 10(5): e0127778. DOI:10.1371/journal.pone. 0127778.
[10]FAN K J, YANG B, LIU Y, et al. Inhibition of human lung cancer proliferation through targeting stromal fibroblasts by dihydromyricetin[J]. Mol Med Rep, 2017, 16(6): 9758-9762. DOI: 10.3892/ mmr.2017.7802.
[11]XU Y, WANG S, CHAN H F, et al. Dihydromyricetin induces apoptosis and reverses drug resistance in ovarian cancer cells by p53mediated downregulation of survivin[J]. Sci Rep, 2017, 7: 46060. DOI: 10.1038/srep46060.
[12]WANG Z, SUN X, FENG Y, et al. Dihydromyricetin reverses MRP2mediated MDR and enhances anticancer activity induced by oxaliplatin in colorectal cancer cells[J]. Anticancer Drugs, 2017, 28(3): 281-288. DOI: 10.1097/CAD. 0000000000000459.
[13]RIZWANULLAH M, AMIN S, MIR S R, et al. Phytochemical based nanomedicines against cancer: current status and future prospects[J]. J Drug Target, 2017: 1-22. DOI: 10.1080/1061186X.2017.1408115.
[14]CHIKARA S, NAGAPRASHANTHA L D, SINGHAL J, et al. Oxidative stress and dietary phytochemicals: role in cancer chemoprevention and treatment[J]. Cancer Lett, 2018, 413: 122-134. DOI: 10.1016/j.canlet.2017.11.002.
[15]ZHU W, DU Y, MENG H, et al. A review of traditional pharmacological uses, phytochemistry, and pharmacological activities of tribulus terrestris [J]. Chem Cent J, 2017, 11(1): 60. DOI: 10.1186/ s130650170289x.
[16]雷华平, 冯纪南, 任名新, 等. 不同季节的显齿蛇葡萄中二氢杨梅素和总黄酮的含量测定[J].中国野生植物资源, 2017, 36(1): 37-39. DOI: 10.3969/j.issn.10069690.2017. 01.011.
LEI H P, FENG J N, REN M X, et al. Determination of dihydromyricetin and total flavones in ampelopis grossedentata in different seasons [J]. Chin Wild Plant Resources, 2017, 36(1): 37-39. DOI: 10.3969/j.issn.10069690.2017. 01.011.
[17]TAO Y, YANG S, WU Y, et al. MicroRNA216a inhibits the metastasis of gastric cancer cells by targeting JAK2/STAT3mediated EMT process[J]. Oncotarget, 2017, 8(51): 88870-88881. DOI: 10. 18632/oncotarget.21488.
[18]WANG N, LI Y, ZHOU J. miR31 functions as an oncomir which promotes epithelialmesenchymal transition via regulating BAP1 in cervical cancer[J]. Biomed Res Int, 2017, 2017: 6361420. DOI: 10.1155/2017/6361420.
[19]SHIN D H, KWON G S. Preclinical evaluation of a themosensitive gel containing epothilone B and mTOR/Hsp90 targeted agents in an ovarian tumor model[J]. J Control Release, 2017, 268: 176-183. DOI: 10.1016/j. jconrel.2017.10.022.
[20]XU S, GE J, ZHANG Z, et al. MiR129 inhibits cell proliferation and metastasis by targeting ETS1 via PI3K/AKT/mTOR pathway in prostate cancer[J]. Biomed Pharmacother, 2017, 96: 634-641. DOI: 10.1016/j.biopha.2017.10.037.
[21]PEI Z, FU W, WANG G. A natural product toosendanin inhibits epithelialmesenchymal transition and tumor growth in pancreatic cancer via deactivating Akt/mTOR signaling[J]. Biochem Biophys Res Commun, 2017, 493(1): 455-460. DOI: 10.1016/j.bbrc.2017.08.170

相似文献/References:

[1]朱宁生,张婧,曾晓华,等.BMP-4基因影响乳腺癌细胞增殖、凋亡和迁移能力涉及NF-κB途径[J].第三军医大学学报,2012,34(18):1910.
[2]陈显春,杨英,宋爽,等.乳腺癌患者发生化疗性静脉炎的原因分析及防治对策[J].第三军医大学学报,2007,29(21):2055.
[3]张毅,周艳,郭美琴,等.全乳大切片观察新辅助化疗后乳腺癌浸润性生长特征变化[J].第三军医大学学报,2007,29(21):2083.
 ZHANG Yi,ZHOU Yan,GUO Mei-qin,et al.Infiltrating characteristics of breast cancer after neoadjuvant chemotherapy: whole breast serial subsection observation[J].J Third Mil Med Univ,2007,29(18):2083.
[4]陈显春,杨英,宋爽,等.乳腺癌病友联谊会对提高乳腺癌患者生活质量的作用[J].第三军医大学学报,2007,29(20):1967.
[5]邓莉,张轩珍,王卫东,等.重组人内皮抑素联合紫杉醇+顺铂化疗方案治疗人乳腺癌祼鼠移植瘤的研究[J].第三军医大学学报,2008,30(09):783.
 DENG Li,ZHANG Xuan-zhen,WANG Wei-dong,et al.Recombinant human endostatin combined with paclitaxel-cisplatin chemotherapy in treatment of human breast cancer xenograft in nude mice[J].J Third Mil Med Univ,2008,30(18):783.
[6]黄红梅,陈显春.男性乳腺癌患者的心理分析及对策[J].第三军医大学学报,2007,29(23):2222.
[7]杨新华,姜军,范林军,等.乳腺癌腔镜内乳淋巴结清扫的初步研究[J].第三军医大学学报,2007,29(17):1719.
 YANG Xin-hua,JIANG Jun,FAN Lin-jun,et al.Thoracoscopic internal mammary nodes dissection for breast cancer[J].J Third Mil Med Univ,2007,29(18):1719.
[8]廖翠薇,邹利光,戴书华,等.动态增强磁共振成像对乳腺癌的诊断[J].第三军医大学学报,2008,30(16):1516.
 LIAO Cui-wei,ZOU Li-guang,DAI Shu-hua,et al.Diagnosis of breast cancer with dynamic contrast-enhanced magnetic resonance imaging[J].J Third Mil Med Univ,2008,30(18):1516.
[9]张涛,汤为学,蔡辉,等.不同转移潜能乳腺癌细胞亚系的建立与生物学特性的分析[J].第三军医大学学报,2008,30(18):1726.
 ZHANG Tao,TANG Wei-xue,CAI Hui,et al.Establishment of breast cancer cell sublines with different potential of metastasis and their biological characteristics[J].J Third Mil Med Univ,2008,30(18):1726.
[10]李霞,邓华瑜.格尔德霉素对乳腺癌细胞HSP、突变型p53和CDK4表达的影响[J].第三军医大学学报,2007,29(13):1320.
 LI Xia,DENG Hua-yu.Effects of geldanamycin on expression of HSP, mutant p53 and CDK4 in human breast cancer cells[J].J Third Mil Med Univ,2007,29(18):1320.

更新日期/Last Update: 2018-09-28